These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 158103)

  • 1. [Deviation in steroid hormone secretion in essential hypertension].
    Ojima M
    Nihon Rinsho; 1979 Jun; 37(6):1275-82. PubMed ID: 158103
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
    Melby JC; Dale SL
    Mayo Clin Proc; 1977 May; 52(5):317-22. PubMed ID: 870774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of corticosteroids by the perfused rat adrenal cortex [proceedings].
    Sibley CP; Whitehouse BJ; Vinson GP; McCredie E
    J Endocrinol; 1979 Oct; 83(1):36P. PubMed ID: 230273
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenal steroidogenesis in "low renin" or hyporeninemic hypertension.
    Melby JC; Dale SL
    J Steroid Biochem; 1975 May; 6(5):761-6. PubMed ID: 1186255
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract]   [Full Text] [Related]  

  • 6. [Importance of the simultaneous estimation of aldosterone, 18-hydroxy-11-deoxycorticosterone and cortisol in the adrenal veins in arterial hypertension with suppressed renin (author's transl)].
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Sb Lek; 1977 Jan; 79(1):1-10. PubMed ID: 841259
    [No Abstract]   [Full Text] [Related]  

  • 7. 18-hydroxy-11-deoxycorticosterone response to ACTH, insulin and furosemide administration in essential hypertensive patients.
    Tosti-Croce C; Giaquinto G; Graziosi S; Odoardi A; Sparano F; Sciarra F
    Horm Res; 1981; 15(1):28-36. PubMed ID: 6277757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocorticosteroids in experimental and human hypertension.
    Melby SC; Dale SL
    J Endocrinol; 1979 May; 81(2):93P-106P. PubMed ID: 458347
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of the anterior pituitary gland in the regulation of 18-hydroxydesoxycorticosterone by the adrenal cortex].
    Bobkova AS; Golikov PP
    Probl Endokrinol (Mosk); 1980; 26(4):51-5. PubMed ID: 6251446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension.
    Taylor AA; Mitchell JR; Bartter FC; Snodgrass WR; McMurtry RJ; Gill JR; Franklin RB
    J Clin Invest; 1978 Jul; 62(1):162-8. PubMed ID: 149141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New mineralocorticoids and adrenocorticosteroids in hypertension.
    Melby JC; Dale SL
    Am J Cardiol; 1976 Nov; 38(6):805-13. PubMed ID: 136892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic aldosterone and 18-hydroxydeoxycorticosterone studies in labile and stable benign essential hypertension.
    Nowaczynski W; Kuchel O; Genest J; Messerli FH; Honda M; Tolis G; Seth K; Parvin-Pande R; Kubo S; Grose J; Ledoux F; Lebel M
    J Steroid Biochem; 1975 May; 6(5):767-78. PubMed ID: 171513
    [No Abstract]   [Full Text] [Related]  

  • 13. Aldosterone and renin in essential hypertension.
    Genest J; Nowaczynski W; Boucher R; Kuchel O; Rojo-Ortega JM
    Can Med Assoc J; 1975 Sep; 113(5):421-31. PubMed ID: 1098756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Etiological studies of essential hypertension. B. Steroid hormones other than aldosterone].
    Kumagai A; Tamura Y; Nishikawa T
    Nihon Rinsho; 1984 Feb; 42(2):277-81. PubMed ID: 6716684
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mineralocorticoid excess in essential hypertension].
    Kumagai A; Tamura Y
    Nihon Rinsho; 1979 Oct; 37(10):3393-7. PubMed ID: 160470
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physiological regulation and clinical significance of 18-hydroxy-11-deoxycorticosterone].
    Li G; Kuang AK; Ding T
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):94-7, 126. PubMed ID: 2985345
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Effects of 18-hydroxydeoxycorticosterone on stress-induced release of corticotrophin.
    Tiptaft E; Jones MT
    J Endocrinol; 1976 Jun; 69(3):33P-34P. PubMed ID: 181512
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioimmunoassay of free urinary 18-hydroxydeoxycorticosterone (18-OH-DOC) in patients with essential hypertension.
    Hornung J; Gless KH; Abdelhamid S; Vielhauer W; Vecsei P
    Clin Chim Acta; 1978 Jul; 87(2):181-7. PubMed ID: 657546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid properties of potential metabolites of 18-hydroxydeoxycorticosterone and 18-hydroxyprogesterone.
    Weet JF; Lenz GR
    J Med Chem; 1985 Feb; 28(2):233-9. PubMed ID: 3155800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man.
    Williams GH; Braley LM; Underwood RH
    J Clin Invest; 1976 Jul; 58(1):221-9. PubMed ID: 180059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.